News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
324,066 Results
Type
Article (16049)
Company Profile (301)
Press Release (307710)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (91846)
Career Advice (171)
Deals (16277)
Drug Delivery (39)
Drug Development (53919)
Employer Resources (31)
FDA (6972)
Job Trends (5579)
News (165723)
Policy (12356)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (968)
Accelerated approval (20)
Adcomms (14)
Allergies (97)
Alliances (26203)
ALS (129)
Alzheimer's disease (1109)
Antibody-drug conjugate (ADC) (270)
Approvals (7211)
Artificial intelligence (279)
Autoimmune disease (125)
Automation (9)
Bankruptcy (111)
Best Places to Work (4797)
BIOSECURE Act (6)
Biosimilars (120)
Biotechnology (233)
Bladder cancer (105)
Brain cancer (49)
Breast cancer (386)
Cancer (3332)
Cardiovascular disease (242)
Career advice (156)
Career pathing (8)
CAR-T (230)
CDC (5)
Cell therapy (591)
Cervical cancer (15)
Clinical research (46669)
Collaboration (1243)
Company closure (2)
Compensation (615)
Complete response letters (43)
COVID-19 (1192)
CRISPR (88)
C-suite (587)
Cystic fibrosis (112)
Data (4561)
Denatured (15)
Depression (101)
Diabetes (271)
Diagnostics (1845)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (202)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (221)
Earnings (36213)
Editorial (27)
Employer branding (4)
Employer resources (29)
Events (55786)
Executive appointments (654)
FDA (8898)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1032)
Gene editing (185)
Generative AI (23)
Gene therapy (511)
GLP-1 (543)
Government (1271)
Grass and pollen (4)
Guidances (186)
Healthcare (7156)
HIV (18)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (196)
Immuno-oncology (43)
Indications (77)
Infectious disease (1313)
Inflammatory bowel disease (163)
Inflation Reduction Act (10)
Influenza (52)
Intellectual property (179)
Interviews (18)
IPO (8192)
IRA (13)
Job creations (1049)
Job search strategy (138)
JPM (42)
Kidney cancer (9)
Labor market (24)
Layoffs (248)
Leadership (10)
Legal (2153)
Liver cancer (51)
Longevity (11)
Lung cancer (457)
Lymphoma (260)
Machine learning (24)
Management (7)
Manufacturing (419)
MASH (136)
Medical device (3625)
Medtech (3640)
Mergers & acquisitions (8795)
Metabolic disorders (765)
Multiple sclerosis (113)
NASH (13)
Neurodegenerative disease (243)
Neuropsychiatric disorders (74)
Neuroscience (2078)
Neurotech (1)
NextGen: Class of 2026 (2156)
Non-profit (907)
Now hiring (31)
Obesity (343)
Opinion (125)
Ovarian cancer (135)
Pain (108)
Pancreatic cancer (173)
Parkinson's disease (241)
Partnered (14)
Patents (322)
Patient recruitment (362)
Peanut (44)
People (29298)
Pharmaceutical (44)
Pharmacy benefit managers (10)
Phase 1 (16172)
Phase 2 (21478)
Phase 3 (14024)
Pipeline (3567)
Policy (91)
Postmarket research (992)
Preclinical (6778)
Press Release (32)
Prostate cancer (153)
Psychedelics (50)
Radiopharmaceuticals (248)
Rare diseases (673)
Real estate (1904)
Recruiting (12)
Regulatory (11542)
Reports (23)
Research institute (1019)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (130)
Series A (189)
Series B (148)
Service/supplier (1)
Sickle cell disease (79)
Special edition (19)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2211)
State (1)
Stomach cancer (6)
Supply chain (36)
Tariffs (18)
The Weekly (62)
Vaccines (366)
Venture capital (73)
Weight loss (177)
Women's health (27)
Worklife (2)
Date
Today (13)
Last 7 days (271)
Last 30 days (1201)
Last 365 days (18835)
2026 (2127)
2025 (19160)
2024 (21851)
2023 (23973)
2022 (30256)
2021 (31144)
2020 (26603)
2019 (18342)
2018 (13442)
2017 (15640)
2016 (13742)
2015 (16812)
2014 (12453)
2013 (9312)
2012 (9526)
2011 (9709)
2010 (9315)
Location
Africa (208)
Alabama (65)
Alaska (2)
Arizona (79)
Arkansas (5)
Asia (31382)
Australia (4584)
California (7311)
Canada (2011)
China (914)
Colorado (249)
Connecticut (260)
Delaware (239)
Europe (46959)
Florida (938)
Georgia (213)
Hawaii (2)
Idaho (17)
Illinois (411)
India (47)
Indiana (170)
Iowa (8)
Japan (371)
Kansas (84)
Kentucky (9)
Louisiana (7)
Maine (13)
Maryland (797)
Massachusetts (5863)
Michigan (113)
Minnesota (277)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (41)
New Hampshire (21)
New Jersey (1812)
New Mexico (13)
New York (1854)
North Carolina (864)
North Dakota (6)
Northern California (3595)
Ohio (181)
Oklahoma (11)
Oregon (25)
Pennsylvania (1313)
Puerto Rico (9)
Rhode Island (27)
South America (280)
South Carolina (9)
Southern California (2897)
Tennessee (40)
Texas (932)
United States (24428)
Utah (117)
Virginia (138)
Washington D.C. (38)
Washington State (599)
West Virginia (1)
Wisconsin (50)
324,066 Results for "carrick therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
December 11, 2025
·
5 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Business
Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts and Appoints David Sutherland, CPA, as Vice President of Finance and Controller
Carrick Therapeutics Inc. today announced the relocation of its corporate headquarters from Dublin, Ireland to Boston, Massachusetts.
June 5, 2024
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
·
8 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Upcoming December 2025 Investor Conference
December 3, 2025
·
1 min read
Press Releases
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
December 3, 2025
·
4 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
December 17, 2025
·
1 min read
Press Releases
Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven Patient Selection for Samuraciclib (CDK7i) in Combination with SERDs in Hormone Receptor Positive Advanced Breast Cancer
May 15, 2025
·
4 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
October 14, 2025
·
1 min read
Drug Development
Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
Carrick Therapeutics today announced that the first patient has been dosed in its Phase 1b/2 clinical trial evaluating the combination of samuraciclib (CT7001).
February 14, 2024
·
4 min read
1 of 32,407
Next
